FDA Warning Letter — Imprimis NJOF, LLC
The FDA took a Warning Letter action against Imprimis NJOF, LLC on June 7, 2019 (Ledgewood, NJ). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.
Action Details
- Facility
- Imprimis NJOF, LLC
- Date
- June 7, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Center
- CDER
- Location
- Ledgewood, NJ (United States)